Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market
Holding FULC?
Track your performance easily

Fulcrum Therapeutics (FULC) Financial Statements

495 Followers

Fulcrum Therapeutics Financial Overview

Fulcrum Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.35; its P/E ratio is -9.15; Fulcrum Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 80.00M-$ 871.00K$ 759.00K$ 880.00K
Gross Profit$ 80.00M-$ 871.00K$ 759.00K$ 880.00K
EBIT$ 55.41M$ -29.83M$ -27.99M$ -24.02M$ -23.78M
EBITDA$ 56.95M$ -29.36M$ -27.48M$ -25.07M$ -23.18M
Net Income Common Stockholders$ 55.41M$ -26.87M$ -24.76M$ -24.02M$ -23.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 273.78M$ 213.31M$ 236.22M$ 257.09M$ 278.16M
Total Assets$ 294.26M$ 232.59M$ 257.69M$ 278.88M$ 300.33M
Total Debt$ 9.65M$ 10.14M$ 10.82M$ 11.49M$ 12.16M
Net Debt$ -264.13M$ -203.18M$ -225.40M$ -245.60M$ -266.00M
Total Liabilities$ 20.47M$ 19.00M$ 22.50M$ 23.42M$ 24.90M
Stockholders Equity$ 273.82M$ 213.63M$ 235.19M$ 255.46M$ 275.43M
Cash Flow-
Free Cash Flow$ 58.90M$ -25.31M$ -23.23M$ -22.97M$ 3.96M
Operating Cash Flow$ 58.90M$ -25.28M$ -23.16M$ -22.91M$ 3.96M
Investing Cash Flow$ -12.51M$ 38.13M$ 18.35M$ 19.02M-
Financing Cash Flow$ 377.00K$ 1.65M$ 287.00K--
Currency in USD

Fulcrum Therapeutics Earnings and Revenue History

Fulcrum Therapeutics Debt to Assets

Fulcrum Therapeutics Cash Flow

Fulcrum Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis